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Edited by Horst FeldmannAbstract This paper summarizes results of the 40-year studies
on replication and recombination of RNA molecules in the cell-
free ampliﬁcation system of bacteriophage Q. Special attention
is paid to the molecular colony technique that has provided for
the discovery of the nature of ‘‘spontaneous’’ RNA synthesis by
Q replicase and of the ability of RNA molecules to spontane-
ously rearrange their sequences under physiological conditions.
Also discussed is the impact of these data on the concept of RNA
World and on the development of new in vitro cloning and
diagnostic tools.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The 40th anniversary of FEBS is a good occasion to com-
memorate two remarkable events that also have occurred four
decades ago: the ﬁrst report on the exchange of genetic in-
formation at the RNA level and the ﬁrst cell-free exponential
ampliﬁcation of a nucleic acid.
In the beginning of the 1960s, Hirst [1] and Ledinko [2] re-
ported on the exchange of genetic markers between related
strains of poliovirus whose genome is composed of RNA.
Although it was not precisely known at that time if the entire
poliovirus genome consists of one RNA molecule and if the
involvement of DNA intermediates can be absolutely ex-
cluded, these reports are commonly cited as marking the dis-
covery of intermolecular RNA recombination, i.e., an
exchange between RNA molecules with their segments. Any-
way, those reports have made RNA recombination a matter of
experimental research. At about the same time, the ﬁrst RNA
‘‘replicase’’ (an enzyme capable of synthesizing RNA on an
RNA template) was discovered in the lysates of E. coli cells
infected with an RNA bacteriophage [3] and, slightly later, the
exponential ampliﬁcation of RNA was demonstrated in a cell-
free system [4]. That system employed Qb replicase, the RNA-* Fax: +7-095-924-0493.
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Abbreviations: RQ RNA, a non-genomic RNA capable of exponential
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doi:10.1016/j.febslet.2004.03.066dependent RNA polymerase of bacteriophage Qb, and up to
date it remains the only cell-free system capable of exponen-
tially amplifying RNA. The two discoveries occurred so syn-
chronously that it looked as if the providence delivered to the
researchers a hint to use the cell-free ampliﬁcation system for
studies on RNA recombination. Ironically, the two ﬁelds re-
mained in mutual ignorance for a quarter of century. A reason
for this fact was probably the failure to detect recombination
between RNA phages in experiments analogous to those per-
formed with poliovirus, resulting in a belief that no RNA re-
combination is possible in a prokaryotic system [5]. This view
persisted until 1988, when a natural Qb replicase-ampliﬁable
RNA was found whose recombinant origin was unequivocally
demonstrated by sequencing [6].
This paper gives an updated review of in vitro studies on
RNA replication and recombination in the Qb ampliﬁcation
system and shows how their results help to imagine a likely
scenario of the evolution in the RNA World, to unveil the role
of RNA recombination in the contemporary DNAWorld, and
to develop new genetic and diagnostic tools. A detailed review
of earlier data can be found elsewhere [7].2. Qb replicase templates
In addition to the 4217 nt-long genomic Qb RNA, Qb rep-
licase ampliﬁes a number of RQ RNAs (termed so for being
Replicable by Qb replicase), which are usually 6 250 nt in
length. The natural source of RQ RNAs is Qb phage-infected
E. coli cells [8,9] or Qb phage itself [10]. Recently, many new
RQ RNAs have been selected from random [11] or artiﬁcially
designed [12] sequences, or produced by in vitro RNA re-
combination [13,14]. Approximately, 104 copies of a single
genomic RNA molecule are produced in a Qb phage infected
E. coli cell in less than 1 h [15]. Ampliﬁcation of small RQ
RNAs is much faster: up to 1010 copies are produced at room
temperature within 10 min in a cell-free system composed of
puriﬁed Qb replicase and all four rNTPs [7], and this is the
absolute record of the rate of nucleic acid ampliﬁcation. Since
its discovery, there had been numerous attempts to utilize this
extremely powerful cell-free ampliﬁcation system for the am-
pliﬁcation of desired RNAs, such as mRNAs or ribozymes,
but that proved not an easy task, primarily because the
mechanism Qb replicase uses to recognize its templates is not
known. Like DNA ampliﬁcation in the polymerase chain re-
action (PCR), RNA is ampliﬁed by Qb replicase exponentially.
This means that in each round of replication, the number ofblished by Elsevier B.V. All rights reserved.
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replicase is in molar excess over the RNA ampliﬁed. Unlike
PCR, no oligonucleotide primers and no temperature cycling
are required. This is because Qb replicase synthesizes RNA in
a primer-independent manner, the product strand and its
template are rendered unannealed throughout the replication
round, and both the strands are available to being used as
templates in the next round that commences immediately upon
termination. Furthermore, unlike common DNA-directed
RNA polymerases, Qb replicase does not utilize transcrip-
tional promoters [7]. Yet, it manifests a very high degree of
selectivity in choosing which RNA to amplify: only a few of
1012 unique RNA sequences of 50–77 nt in length ﬂanked by
the correct 50- and 30-terminal clusters are recognized as tem-
plates [11]. This provides a rationale for the fact that Qb
replicase does not amplify most natural RNAs, including any
tested cellular RNAs or genomic RNAs of other viruses [7].3. What makes RNA replicable?
Qb replicase copies its cognate (replicable) RNAs beginning
at the 30-terminal oligo(C) cluster. The cluster is usually 3–4,
sometimes 2 nucleotides long. At the 50 terminus, there is a
matching oligo(G) cluster whose role is believed to code for the
oligo(C) at the 30 end of the complementary product strand
[16]. Except for these terminal clusters, too short to provide for
the observed selectivity, no other sequence common to all
known replicable RNAs has been found. Other structural
similarities were also noted, such as internal 8–15 nt-long py-
rimidine-rich segments [11,17], the unpaired 30 end, and a
hairpin involving the 50 end [12,18], but artiﬁcial RNAs
designed to accommodate these features turned out to be non-
replicable [12,19].
Recently [20] we found that if RQ135 RNA (a replicable
species having 135 nt in length [21]) was cleaved into two
fragments, neither of them could be ampliﬁed, which was ex-
pected because the integrity of the template was lost and its
terminal clusters occurred in separate molecules. However,
unexpectedly, each fragment appeared to be capable of
directing the synthesis of its respective complementary copy,
although the initiator oligo(C) cluster resided on the 30 frag-
ment only. To explore the unusual template activity of the 50
fragment, we prepared an array of its variants with altered
initiation regions and found that every variant can be copied,
although with varying eﬃciency. However, template properties
of the 50 fragment variants, even those bearing oligo(C) clus-
ters at the 30 end, turned out to be entirely diﬀerent from the
properties of ‘‘legitimate’’ templates, the intact RQ135 RNA
and its 30 fragment. Most importantly, in contrast to the
legitimate templates, none of the 50 fragment variants was
capable of the GTP-dependent formation of a stable replica-
tive complex capable of elongation in the presence of aurin-
tricarboxylic acid, a powerful inhibitor of RNA protein
interactions. This was, in spite of the fact that each of the 50
fragment variants inherited a pyrimidine-rich segment of the
RQ135 RNA [17] and many of them possessed the secondary
structure elements thought to be diagnostic features of repli-
cable RNAs [12,18].
Thus, although Qb replicase can initiate and elongate on a
variety of RNAs, only some of them are recognized as legiti-
mate templates. The results further suggest that the diagnosticfeature discriminating between legitimate and illegitimate
templates is a GTP-dependent step in initiation that induces a
‘‘closed’’ conformation of the replicative complex, which does
not dissociate until the product strand is completed. A plau-
sible role of the closed conformation is to render the comple-
mentary template and nascent strands non-paired, thereby
providing for the exponential RNA ampliﬁcation [20]. The
structural features of legitimate templates, which determine the
Qb replicase commitment to entering the closed conformation
and, ultimately, its template speciﬁcity, remain to be eluci-
dated.4. RQ RNAs as ampliﬁcation vectors
In the absence of knowledge of the replication mechanism,
there were attempts to amplify heterologous sequences by us-
ing natural replicating RNAs as vectors. To this end, a foreign
sequence was embedded into an internal loop of an RQ RNA
in such a manner as to minimally disturb the RNA tertiary
structure. The ﬁrst successful attempt of this sort made in 1983
[22] was given a great deal of enthusiasm by being declared to
be the birth of recombinant RNA technology [23]. Later,
however, it was understood that there are severe constraints on
the embedded sequence: it should be highly structured and be
no longer than about hundred nucleotides [24,25]. Common
mRNAs could be ampliﬁed within RQ vectors only in vivo [26]
or in the presence of a coupled cell-free translation system [27].
In these cases, ampliﬁcation becomes possible because trans-
lating ribosomes coat the coding (sense) strand, thereby pre-
venting its annealing with the antisense strand. Otherwise, the
complementary strands would collapse into duplex, resulting
in immediate cessation of RNA synthesis. However, inasmuch
as ribosomes occupy sense strands and read them in opposite
direction than Qb replicase does, only antisense strands remain
available as replicase templates. Therefore, ampliﬁcation
becomes asymmetric and rather linear than exponential [27].
Also, there were attempts to employ RQ RNA vectors,
carrying short insert complementary to a target, as replicable
probes for diagnostic purposes. The background RNA syn-
thesis caused by non-speciﬁcally bound probes was eliminated
by introducing compound binary probes consisting of two
fragments capable of producing the full-sized replicable RNA
when ligated upon hybridization next to one another on a
target molecule if this is present in the analyzed sample [28].
However, this approach has not become a routine assay be-
cause even short inserts often inhibit replication of RQ RNA
vectors, and because binary RNA probes can self-recombine to
produce replicable RNAs in the absence of any target or ligase
(see below).5. RNA recombination can occur in the Qb system
For a long time it was held that no RNA recombination
could occur in bacterial cells, as far as all attempts to detect
recombinant progeny upon co-infection of E. coli cells with
RNA bacteriophages carrying distinct genetic markers were
unsuccessful [5]. This contrasted the ease of observation of
genetic recombinations in poliovirus and some other animal
[29,30] or plant [31] viruses.
A.B. Chetverin / FEBS Letters 567 (2004) 35–41 37The ﬁrst unequivocal evidence of the occurrence of RNA
recombination in prokaryotic systems has been the sequence of
RQ120 RNA, which contains, at the 50 end, an 80-nt segment
of the coat protein cistron of phage Qb RNA and, at the 30
end, the 30-terminal 33-nt segment of E. coli tRNAAsp1 [6].
Remarkably, RQ120 RNA as well as other recombinant RQ
RNAs discovered later, appeared to be a product of crossing-
over between non-homologous sequences at non-homologous
sites [32], in a sharp contrast to picornaviruses (including the
poliovirus) and coronaviruses that manifest predominantly
homologous recombination, in which parental and progeny
RNAs are homologous to each other around the cross-over
site [29,30]. Moreover, when homologous recombination was
ﬁnally demonstrated for phage Qb in specially designed
experiments [33], it turned out to be a million times less fre-
quent than in poliovirus, suggesting that diﬀerent mechanisms
may operate in these viruses [34].6. The puzzle of spontaneous RNA synthesis
Once the occurrence of RNA recombination in Qb phage-
infected bacteria was established, demonstration of RNA re-
combination in the cell-free replication system would seem a
technical matter. For example, one might mix the non-repli-
cable 50 and 30 fragments of RQ RNA discussed above, incu-
bate them with Qb replicase and rNTPs and see if there is
exponential RNA synthesis indicating that the two fragments
have recombined to restore the replicable molecule. However,
experiments of this type could not be carried out because of
intense RNA synthesis that invariably took place in the Qb
replicase system irrespectively of the addition of these frag-
ments or of any other RNA template [35]. The template-
independent synthesis was claimed to be caused by RQ RNAs
contaminating Qb replicase preparations [36], but this was
disputed, because the synthesis still occurred when the enzyme
portion used might not contain even one replicable molecule
[35,37].
The latter observations gave rise to a hypothesis that Qb
replicase can produce replicable RNAs de novo, without any
template, by virtue of random condensation of nucleotides,
with the fortuitous formation of replicable molecules and their
subsequent evolution into rapidly ampliﬁable species [35,38]. If
so, the Qb replicase replication system could serve as an
experimental model wherein replicable molecules are created
within the span of the reaction time (one to few hours).
However, there were facts that could hardly be reconciled withFig. 1. Detection of airborne RQ RNAs using two-layer agarose sandwiches
the upper layer contained Qb replicase. The upper layer was cast without exp
The experiments were carried out in a room where RQ RNAs were often usthe de novo hypothesis. Thus, many RNAs isolated from the
products of spontaneous synthesis turned out to be either
identical to RQ RNAs isolated earlier or recombinants con-
sisting of long pieces of other known RNAs (the above men-
tioned RQ120 RNA was one of them) [7]. This suggested that
synthesis of these RNAs was in fact template-instructed, but
how did those templates occur in the reaction mixture?7. Detection of airborne RQ RNAs with the molecular colony
technique
A similar problem was solved in 1860s by Louis Pasteur [39]
who disproved the doctrine of spontaneous generation of life
from non-living organic matter by demonstrating that no life
could arise in a boiled meat broth unless solid particles heavier
than air were allowed to enter. Those experiments also con-
vincingly demonstrated that microorganisms are everywhere –
even in the air.
Unfortunately, Pasteur’s approach could not be used in this
case, since boiling or otherwise killing of RNA would also kill
Qb replicase. Yet the source of RNA templates could be found
out if it was possible to precisely monitor the number of RQ
RNA molecules in the reaction mixture. Such a possibility was
provided by the molecular colony technique (MCT), invented
in this laboratory [10]. The idea of experiment was to carry out
RNA ampliﬁcation in a gel, rather than in solution. In this
format, the copies of each replicable molecule would concen-
trate around the original template, giving rise to a molecular
colony. By counting the number of RNA colonies one could
determine how many replicable molecules had been entrapped
in the gel. An ideologically similar approach was used by
Robert Koch in 1881 [40], who demonstrated the formation of
bacterial colonies in solidiﬁed culture media.
Fig. 1 shows Petri dishes in which the experiments were
carried out. In each dish, two agarose layers were cast one on
top of the other. The lower layer contained rNTP substrates,
and the upper layer, prepared at the speciﬁed time, contained
Qb replicase. The RNA colonies grew on the interface between
the layers and were made visible by staining with ethidium
bromide. It is seen that, if the enzyme layer was cast immedi-
ately after solidiﬁcation of the substrate layer (Fig. 1A), the
number of RNA colonies was lower, than if it was cast 1 h later
(Fig. 1B). Even fewer colonies grew if the layers were cast in a
room where no experiments with RQ RNAs had been previ-
ously carried out (Fig. 1C). These experiments demonstrated
that, like Pasteur’s germs, RQ RNAs invade the reactionprepared in 35 mm Petri dishes [10]. The lower layer contained rNTPs,
osure (A, C) or after a one-hour exposure of the lower layer to air (B).
ed (A, B) or in a remote room (C).
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template-independent reactions as the failure to prevent RNA
synthesis by exhaustive puriﬁcation of Qb replicase and the
reproducible generation of the same RQ RNA species in in-
dependent experiments and in diﬀerent laboratories [7].
The last argument of the advocates of the de novo hypoth-
esis was that replicable RNA species arose even in sealed
capillaries after periods of time much longer than would be
needed for a single RQ RNA molecule to produce detectable
progeny [18,41]. However, the sequence of at least some of the
produced RNAs [18] appeared to be a mosaic of pieces of
RNAs studied in that laboratory [7], suggesting that the rep-
licable species had been generated by recombination from non-
replicating RNA fragments. Thus, we can repeat after Pasteur
that ‘‘there is no known circumstance in which it can be con-
ﬁrmed that microscopic beings come into the world without
germs, without parents similar to themselves’’ (as cited in [42]).8. Use of the molecular colony technique to monitoring RNA
recombination
Detection of airborne RQ RNAs has been the ﬁrst appli-
cation of MCT. These experiments demonstrated diagnostic
potential of MCT by revealing its ability to detect even solitaryFig. 2. Recombination between supplementing 50 and 30 fragments of an RQ
in the recombinants generated in the presence of Qb replicase (Samatov, T.R.
protein [14]. Black letters indicate sequences derived from RQ135 RNA [21],
indicate homologous segments. C: Time course of the generation of replicabl
the presence of 10 mMMgCl2 and buﬀer (10 mM Tris–HCl, pH 8.0, 100 mM
with 32P-labeled probes.‘‘infectious’’ molecules. The advantages of MCT as a diag-
nostic tool are discussed later. In this section, I will consider
the utility of MCT to monitoring chemical reactions between
single molecules; in particular, to studying RNA recombina-
tion. Earlier, RNA recombination was exclusively studied
in vivo, using viruses and their defective genomes ampliﬁed in
living cells. However, because of limitations of the in vivo
systems, those studies could not answer even such basic
questions as whether the recombination is performed by viral
replicase, by host cell proteins, or by RNA molecules them-
selves. Moreover, the in vivo studies did not deﬁnitely rule out
the involvement of DNA intermediates and, therefore, the
possibility that recombination occurs at the DNA, rather than
at the RNA, level.
Due to its ability to detect even single replicable RNA
molecules, MCT allows RNA recombination experiments to
be carried out in vitro as easily as in vivo, but without
restraints inherent to the in vivo systems. To observe RNA
recombination in vitro, the above mentioned non-replicable 50
and 30 fragments of RQ RNA are mixed and seeded on a Qb
replicase containing agarose layer, which is then covered with a
nylon membrane impregnated with rNTPs [13]. The role of the
nylon membrane is to retard diﬀusion of RNA molecules by
reversibly binding them, thereby reducing the size of RNA
colonies and hence increasing the resolving power of MCTRNA. A: Nucleotides that become joined (connected with yellow lines)
and Chetverin, A.B., unpublished data). B: Same in the absence of any
colored letters indicate artiﬁcial extensions of the fragments, red letters
e RNAs by self-recombination from the 50 and 30 fragments at 37 C in
NaCl, 1 mM EDTA) [14]. RNA colonies are detected by hybridization
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of recombination molecules in which the two fragments are
arranged in the manner as they are in the original RQ RNA.
Such molecules are replicable and produce RNA colonies
whose number reﬂects the recombination frequency.
In accordance with the in vivo data, recombination in this
cell-free system appeared to be non-homologous and occurred
at a frequency characteristic of non-homologous recombination
in RNA viruses, 105/nt [34]. Inasmuch as the system con-
tained only pure Qb replicase and rNTPs, one could conclude
that no cellular proteins or DNA intermediates were involved.
Recombination was virtually prevented by periodate oxidation
of the 50 fragment eliminating its 30-terminal hydroxyl group.
This fact, as well as the recombinant sequences (Fig. 2A), was
consistent with the hypothesis that recombination is brought
about by a transesteriﬁcation reaction in which the free 30 hy-
droxyl of the 50 fragment attacks phosphodiester bonds or the
50-terminal triphosphate group of the 30 fragment [13].9. RNA molecules are intrinsically recombinogenic
From the above results it was not clear whether the reaction
between RQ RNA fragments was performed by Qb replicase
or by RNA molecules themselves. To explore this alternative,
the experimental scheme was modiﬁed to separate the recom-
bination and replication events [14]. To this end, a mixture of
the RNA fragments was incubated under chosen conditions
and, prior to seeding on the Qb replicase-containing agarose,
the fragments were oxidized to suppress further recombination
by the above mechanism. Hence, RNA colonies would only
grow if recombination had occurred before the oxidation step.
In the absence of Qb replicase and rNTPs, recombination
between the fragments turned out to be several orders of
magnitude slower, suggesting that it is somehow catalyzed by
the replicase. The residual recombination was not due to in-
complete elimination of the 30 hydroxyls, as it might be ex-
pected: repeated oxidation of the fragments either before or
after incubation did not change its rate. Furthermore, its
mechanism appeared to be entirely diﬀerent from the mecha-
nism of the replicase-catalyzed reaction: the fragments react by
internal segments not involving the 30 hydroxyls (Fig. 2B).
Similar reactions can also occur in cis, resulting in deletion of
internal RNA segments [14].
Cross-over sites are randomly distributed (Fig. 2B), indi-
cating that cryptic ribozyme structures are not involved. It
follows that RNA is intrinsically recombinogenic and, inas-
much as self-recombination requires nothing but RNA itself
and Mg2þ, it must be ubiquitous in nature. Most probably,
self-recombination occurs via a Mg2þ-catalyzed RNA cleavage
generating fragments with 20; 30 cyclic phosphate and 50 hy-
droxyl termini, which are then cross-ligated. An alternative
mechanism involving intermediate formation of a branched
structure [44] was apparently excluded by the fact that yeast
debranching ribonuclease, which selectively cleaves the 20–50
internucleotide bonds [45], did not reduce the reaction yield
(Chetverina, H.V. and Chetverin, A.B., unpublished).
The rate of RNA self-recombination is low (Fig. 2C),
109 h1 per internucleotide bond at 37 C [14]. Yet, spon-
taneous rearrangements in RNA sequences might play an
important role in the evolution of both RNA and DNA
genomes. Even if not increased by the action of cellularproteins, this rate provides for the generation of a new re-
combinant RNA in a human cell every minute, yielding up to
1020 recombinant molecules during the life span of the human
body [14]. Reverse transcription and integration of even a
minute fraction of them would provide for a signiﬁcant change
of the human genome, and must be considered among factors
aﬀecting the genetic variability and the probability of sponta-
neous oncogenic transformation.10. Implications for the RNA World
As noted above, there is no evidence that RNA creation/
evolution can be so fast as to generate replicable RNAs from
mononucleotides within hours, but it seems quite likely that
replicable RNAs and their replicases could have arisen on a
much longer timescale on Earth or on some other planet,
giving rise to the RNA World [46].
The studies on the replicable RNAs and their self-recombi-
nation give some clues to what might be likely features of the
RNA World.
(1) RNA colonies [10] might be a primitive, pre-cellular form
of compartmentation. It has been understood that natural
selection works with ensembles of molecules, rather than
with individual molecules. This means that there must be
some kind of compartmentation linking replicase to its
products in order that natural selection be able to identify
a gene that makes a better product [47,48]. Mixed RNA
colonies comprised of more than one RNA species and
growing in moist clays or other porous solids could per-
form the function of such a compartment [48,49]. This
form of compartmentation is not confronted with the
problem of transportation through hydrophobic barriers
that inevitably arise if lipid membranes are employed [48].
(2) Dissemination of RNA molecules through atmosphere [10]
might be a mechanism for the lateral transfer of genetic in-
formation between RNA colonies, an equivalent of sex,
which is required for a high rate of evolution [50].
(3) Spontaneous recombinations and rearrangements of poly-
ribonucleotides [14] might be a mechanism for creation of
complex structures and for producing new combinations of
genetic elements, generating the variability needed for nat-
ural selection [46]. These reactions might be antecedent to
ribozyme functions, and could drive the creation of long ri-
bozyme molecules from short oligonucleotides that had
been generated by nucleotide condensation [49].
There are grounds to believe that studies on the Qb system
will continue to feed the ideas on how the RNA World might
operate. For example, elucidation of the mechanism by which
Qb replicase prevents the template and its complementary
copy from being hydrogen-bonded along the entire length [7]
might help to approach the yet unsolved issue of how this
function could be fulﬁlled by ribozyme replicases [47].11. Applications of the molecular colony technique to in vitro
cloning and diagnostics
Of course, the potentials of MCT are much greater than just
the demonstration of airborne replicable RNAs and the studies
on RNA recombination. The unique feature of MCT distin-
guishing it from other methods for nucleic acid ampliﬁcation is
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weakening or (given that the sample is properly diluted)
complete elimination of a competition between the molecular
species; allows the individual ampliﬁable molecules to be
monitored, counted and analyzed; provides for a direct high-
throughput screening of a large number of molecules; and
makes the isolation of homogeneous molecule populations
(cloning) possible. Therefore, the most obvious applications of
MCT would seem to be cell-free molecular cloning and
molecular diagnostics. Unfortunately, the structural restraints
Qb replicase imposes upon its templates and the ability of
RNAs to self-recombine (see above) limit the utility of the Qb
replicase version of MCT for these purposes. However, MCT
can utilize any enzymatic reaction that provides for the ex-
ponential ampliﬁcation of nucleic acids [51], e.g., PCR or
isothermal ampliﬁcation reactions, such as 3SR (self-sustained
sequence replication [52]) or SDA (strand displacement am-
pliﬁcation [53]). The most promising results were obtained
using the PCR version of MCT (PCR-MCT) [51], also termed
‘‘polony’’ (polymerase colony) technology [54]. Since PCR
involves repeated sample heating, thermostable media, such as
a polyacrylamide gel, are used in place of the agarose gel.
One of the most promising applications of PCR-MCT is
molecular diagnostics. MCT format digitalizes the assay; it
makes single target molecules visible and their quantitation
straightforward, by simply counting the number of molecular
colonies. MCT format has been shown to be capable of
eliminating any competition between diﬀerent targets, even ifFig. 3. Assay of RNA and DNA targets with the PCR version of the mole
multiplex assay. Colonies produced by 300 molecules of human immunodeﬁci
of concurrently amplifying molecules of human hepatitis B virus (HBV) DNA
hybridized with an HIV-1-speciﬁc 32P-labeled probe (top row) and then wi
molecules in human blood. Total nucleic acids were isolated from 60-ll aliq
contain the indicated number of HBV DNA molecules, had been added. Th
molecules of the target. (Reprinted from [55] by permission of BioTechniqutheir ratio varies more than million-fold. It also eliminates the
interference from a non-speciﬁc synthesis occurring due to
mishybridization of primers with non-target nucleic acids that
are often present in clinical samples in a trillion-fold excess
over the assayed target (Fig. 3). These features greatly increase
the reliability and sensitivity of molecular diagnostics as
compared to those achievable by the conventional solution
assays [55]. The latest experiments closely mimicking real
clinical diagnostics demonstrate that PCR-MCT detects, in
100-lL human blood aliquots, 100% molecules of DNA tar-
gets and 50% molecules of RNA targets. This corresponds to
the sensitivity of 1 and 2 molecules, respectively (Chetverina,
H.V., Falaleeva, M.V. and Chetverin, A.B., submitted), which
is the highest diagnostic sensitivity ever achieved.
In addition, PCR-MCT has been used for establishing the
physical linkage between distant genetic markers according to
their ability to produce mixed colonies and for precisely
quantifying the relative expression of diﬀerent alleles of the
same gene by counting the number of their respective colonies
[56], single nucleotide polymorphism genotyping and expres-
sion proﬁling of heterogeneous cell populations [57], charac-
terizing various cancer-associated genomic abnormalities [58],
single molecule proﬁling of alternative pre-mRNA splicing
[59], and massively parallel in situ sequencing of DNA frag-
ments ampliﬁed in the form of molecular colonies [60].
Future developments of MCT will include cell-free cloning of
entire genes and expressing (transcribing and translating) them
directly within molecular colonies [51]. This will provide forcular colony technique. A: Lack of competition between targets in a
ency virus type-1 (HIV-1) RNA in the presence of the indicated number
. Each of the nine gels was blotted with a nylon membrane that was ﬁrst
th an HBV-speciﬁc probe (bottom row). B: Detection of HBV DNA
uots of the whole human blood to which diluted samples, expected to
e blood aliquots contained nucleic acids equivalent by weight to 1013
es/Eaton Publishing.)
A.B. Chetverin / FEBS Letters 567 (2004) 35–41 41screening the colonies for the ability of the synthesized proteins
to perform a particular enzymatic reaction or to bind a par-
ticular ligand (including antigens, antibodies, or nucleic acids).
In combination with ribosome display strategies [61,62], this
will provide for the in vitro selection of genes coding for pro-
teins with desired functions, a cell-free alternative to the phage
display. Compared to the traditional in vivo techniques, this is
a true molecular cloning. In this case, there is no need in cloning
vectors, in transformation of cells which is always very ineﬃ-
cient, or in isolation of the cloned nucleic acids – since each
colony comprises a homogenous DNA preparation. Moreover,
the colonies comprise naked RNA or DNA that can be directly
analyzed in situ. In other words, MCT can do everything the
traditional in vivo gene cloning can, and even more.
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